Advertisement
UK markets closed
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.91
    -0.45 (-0.54%)
     
  • GOLD FUTURES

    2,335.00
    -7.10 (-0.30%)
     
  • DOW

    38,467.83
    -35.86 (-0.09%)
     
  • Bitcoin GBP

    51,523.70
    -1,916.94 (-3.59%)
     
  • CMC Crypto 200

    1,384.31
    -39.79 (-2.80%)
     
  • NASDAQ Composite

    15,708.86
    +12.22 (+0.08%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Is Biogen Stock a Buy Now?

Is Biogen Stock a Buy Now?

Moving new medicines to the market can sometimes make biopharmaceutical companies tons of returns. Biogen (NASDAQ: BIIB) just scored a major new drug approval for an Alzheimer's disease therapy, so investors are understandably rushing to evaluate whether to buy the stock. One key factor that could drive Biogen's outperformance in the next few years is the launch of a new neurology medicine.